Selected advances in therapy of urologic cancer--luteinizing hormone releasing hormone (LHRH) and biologic response modifier (BUR). [electronic resource]
Producer: 19881130Description: 27-38 p. digitalISSN:- 0361-7742
- Adenocarcinoma -- pathology
- Buserelin -- administration & dosage
- Clinical Trials as Topic
- Delayed-Action Preparations
- Goserelin
- Humans
- Injections, Subcutaneous
- Interleukin-2 -- therapeutic use
- Male
- Orchiectomy
- Prostatic Neoplasms -- pathology
- Random Allocation
- Recombinant Proteins -- therapeutic use
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.